Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Pudek

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Clinical Biochemistry|August 1, 1984
Artefactual decrease in total protein concentration in patients with monoclonal gammopathies: a method-dependent errorK J Whitlow, A A Nanji, M R Pudek
Clinical Chemistry|August 1, 1987
Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assayI A Kulaots, M R Pudek, D W Seccombe
Clinical Biochemistry|February 10, 1998
Homocyst(e)ine levels in patients on phenytoin therapyG K James, M W Jones, M R Pudek
Journal of Forensic Sciences|May 1, 1987
Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicityD W Seccombe, M R Pudek, K H Humphries
Clinical Pharmacy|May 1, 1984
Interference with serum digoxin assays in neonatesM Levine, S Gill, D W Seccombe, et al.
The New England Journal of Medicine|April 14, 1983
Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapyM R Pudek, D W Seccombe, M F Whitfield, et al.
Clinical Chemistry|June 1, 1982
Effect of macro creatine kinase BB on results of different creatine kinase isoenzyme methodsM R Pudek, B E Jacobson, N Urquhart, et al.
Clinical Chemistry|November 1, 1985
Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kitsM R Pudek, D W Seccombe, B E Jacobson, et al.
Clinical Biochemistry|June 1, 1990
Low concentration galactose determination in plasma adapted to the Cobas-BioM R Pudek, A Jamani, V Bernstein, et al.
Clinical Biochemistry|February 1, 1989
Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertensionD W Seccombe, M R Pudek, W Nowaczynski, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Biochemistry|August 1, 1984
Artefactual decrease in total protein concentration in patients with monoclonal gammopathies: a method-dependent errorK J Whitlow, A A Nanji, M R Pudek
Clinical Chemistry|August 1, 1987
Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assayI A Kulaots, M R Pudek, D W Seccombe
Clinical Biochemistry|February 10, 1998
Homocyst(e)ine levels in patients on phenytoin therapyG K James, M W Jones, M R Pudek
Journal of Forensic Sciences|May 1, 1987
Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicityD W Seccombe, M R Pudek, K H Humphries
Clinical Pharmacy|May 1, 1984
Interference with serum digoxin assays in neonatesM Levine, S Gill, D W Seccombe, et al.
The New England Journal of Medicine|April 14, 1983
Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapyM R Pudek, D W Seccombe, M F Whitfield, et al.
Clinical Chemistry|June 1, 1982
Effect of macro creatine kinase BB on results of different creatine kinase isoenzyme methodsM R Pudek, B E Jacobson, N Urquhart, et al.
Clinical Chemistry|November 1, 1985
Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kitsM R Pudek, D W Seccombe, B E Jacobson, et al.
Clinical Biochemistry|June 1, 1990
Low concentration galactose determination in plasma adapted to the Cobas-BioM R Pudek, A Jamani, V Bernstein, et al.
Clinical Biochemistry|February 1, 1989
Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertensionD W Seccombe, M R Pudek, W Nowaczynski, et al.
Pageof 4